David M. Nathan, MD
David M. Nathan, MD, is currently Director of the Clinical Research Center and of the Diabetes Center at Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School.
Dr. Nathan focuses on the development of innovative therapies to prevent and treat type 1 and type 2 diabetes and to prevent their long-term complications. Dr. Nathan was one of the architects of the landmark Diabetes Control and Complications Trial and chairs its long-term follow-up. Dr. Nathan also chairs the multi-center NIH Diabetes Prevention Program and the GRADE Comparative Effectiveness Study of the treatment of type 2 diabetes. Dr. Nathan led the international Expert Committee on the Diagnosis of Diabetes and the ADA/EASD consensus committee on the treatment of type 2 diabetes between 2005 and 2010. With more than 500 publications, Dr. Nathan is an internationally recognized expert on diabetes. He was awarded the Outstanding Clinician Award by the American Diabetes Association in 2002, its Outstanding Achievement in Clinical Diabetes Research Award in 2015 and the Distinguished Scientist Award by the National Institute of Diabetes Digestive and Kidney Disease, NIH, in 2010.
